Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PACAP (6-38), human, ovine, rat (TFA)

Product Specifications

UNSPSC Description

PACAP (6-38), human, ovine, rat TFA is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively.

Target Antigen

PACAP Receptor

Type

Peptides

Related Pathways

GPCR/G Protein

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/PACAP__6-38_,_human,_ovine,_rat_TFA.html

Purity

98.72

Solubility

DMSO : 100 mg/mL (ultrasonic)|H2O : 50 mg/mL (ultrasonic)

Smiles

O=C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CO)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCSC)C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CC3=CC=C(C=C3)O)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H](CC(C)C)C(NCC(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC4=CC=C(C=C4)O)C(N[C@@H](CCCCN)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(N[C@@H](CC(N)=O)C(N[C@@H](CCCCN)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC5=CC=CC=C5)N.O=C(O)C(F)(F)F

Molecular Weight

4138.76

References & Citations

[1]Gourlet P, et al. Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors. Eur J Pharmacol. 1995 Dec 4;287(1):7-11.|[2]Yang TT, et al. Changes of dopamine content and cell proliferation by dexamethsone via pituitary adenylate cyclase-activating polypeptide in PC12 cell. Neurosci Lett. 2007 Oct 9;426(1):45-8.|[3]Girard BM, et al. Intravesical PAC1 Receptor Antagonist, PACAP(6-38), Reduces Urinary Bladder Frequency and Pelvic Sensitivity in NGF-OE Mice. J Mol Neurosci. 2016 Jun;59(2):290-9.

Shipping Conditions

Blue Ice

Storage Conditions

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-P0220A/PACAP-6-38-human-ovine-rat-TFA-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-P0220A/PACAP-6-38-human-ovine-rat-TFA-SDS-MedChemExpress.pdf

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Human Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) , partial
MBS1391701-01 0.02 mg (E-Coli)

Recombinant Human Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) , partial

Ask
View Details
Recombinant Human Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) , partial
MBS1391701-02 0.1 mg (E-Coli)

Recombinant Human Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) , partial

Ask
View Details
Recombinant Human Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) , partial
MBS1391701-03 0.02 mg (Yeast)

Recombinant Human Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) , partial

Ask
View Details
Recombinant Human Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) , partial
MBS1391701-04 0.1 mg (Yeast)

Recombinant Human Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) , partial

Ask
View Details
Recombinant Human Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) , partial
MBS1391701-05 0.02 mg (Baculovirus)

Recombinant Human Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) , partial

Ask
View Details
Recombinant Human Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) , partial
MBS1391701-06 0.02 mg (Mammalian-Cell)

Recombinant Human Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) , partial

Ask
View Details